| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |